Distance from a Comprehensive Cancer Center: A proxy for poor cervical cancer outcomes?

Gynecologic Oncology

Volumn 143, Issue 3, 2016, Pages 617-621

  Barrington, David A ^a   Dilley, Sarah E ^b   Landers, Emily E ^a   Thomas, Eric D ^b   Boone, Jonathon D ^b   Straughn, J Michael ^b   McGwin, Gerald ^a   Leath, Charles A ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama   (United States)

Author keywords

Cervical cancer; Disparities; Distance; Survival outcomes

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGE; ARTICLE; BODY MASS; CANCER CENTER; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; COHORT ANALYSIS; COMPREHENSIVE CANCER CENTER; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; GEOGRAPHIC DISTRIBUTION; HAZARD RATIO; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MIDDLE AGED; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PELVIS EXENTERATION; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROPORTIONAL HAZARDS MODEL; RACE; RACE DIFFERENCE; RETROSPECTIVE STUDY; SMOKING; UTERINE CERVIX CANCER; ADENOCARCINOMA; ALABAMA; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, SQUAMOUS CELL; DISEASE FREE SURVIVAL; GEOGRAPHY; HEALTH CARE DELIVERY; HEALTH DISPARITY; HEALTH SERVICES RESEARCH; MORTALITY; PATHOLOGY; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; TRAFFIC AND TRANSPORT; TRAVEL; UTERINE CERVICAL NEOPLASMS;

ADENOCARCINOMA; ADULT; ALABAMA; CANCER CARE FACILITIES; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; GEOGRAPHY; HEALTH SERVICES ACCESSIBILITY; HEALTH SERVICES RESEARCH; HEALTH STATUS DISPARITIES; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TRANSPORTATION; TRAVEL; UTERINE CERVICAL NEOPLASMS;

EID: 84992052322     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2016.10.004     Document Type: Article

References (21)

1. [1] Siegel, R.L., Miller, K.D., Jemal, A., Cancer statistics, 2016. CA Cancer J. Clin. 66:1 (2016), 7–30.
2. [2] Harlan, L.C., Greene, A.L., Clegg, L.X., Mooney, M., Stevens, J.L., Brown, M.L., Insurance status and the use of guideline therapy in the treatment of selected cancers. J. Clin. Oncol. 23:36 (2005), 9079–9088.
3. [3] Bristow, R.E., Powell, M.A., Al-Hammadi, N., Chen, L., Miller, J.P., Roland, P.Y., et al. Disparities in ovarian cancer care quality and survival according to race and socioeconomic status. J. Natl. Cancer Inst. 105:11 (2013), 823–832.
4. [4] Collins, Y., Holcomb, K., Chapman-Davis, E., Khabele, D., Farley, J.H., Gynecologic cancer disparities: a report from the Health Disparities Taskforce of the Society of Gynecologic Oncology. Gynecol. Oncol. 133:2 (2014), 353–361.
5. [5] Bristow, R.E., Ueda, S., Gerardi, M.A., Ajiboye, O.B., Ibeanu, O.A., Analysis of racial disparities in stage IIIC epithelial ovarian cancer care and outcomes in a tertiary gynecologic oncology referral center. Gynecol. Oncol. 122:2 (2011), 319–323.
6. [6] Farley, J.H., Hines, J.F., Taylor, R.R., Carlson, J.W., Parker, M.F., Kost, E.R., et al. Equal care ensures equal survival for African–American women with cervical carcinoma. Cancer 91:4 (2001), 869–873.
7. [7] Organization WH, Global Status Report on Noncommunicable Diseases 2014. 2014, World Health Organization, Geneza, Switzerland.
8. [8] Bristow, R.E., Chang, J., Ziogas, A., Anton-Culver, H., Vieira, V.M., Spatial analysis of adherence to treatment guidelines for advanced-stage ovarian cancer and the impact of race and socioeconomic status. Gynecol. Oncol. 134:1 (2014), 60–67.
9. [9] Gunderson, C.C.M.D., Nugent, E.K.M.D., McMeekin, D.S.M.D., Moore, K.N.M.D.M.S., Distance traveled for treatment of cervical cancer: who travels the farthest, and does it impact outcome?. Int. J. Gynecol. Cancer 23:6 (2013), 1099–1103.
10. [10] Leath, C.A. 3rd, Straughn, J.M. Jr., Kirby, T.O., Huggins, A., Partridge, E.E., Parham, G.P., Predictors of outcomes for women with cervical carcinoma. Gynecol. Oncol. 99:2 (2005), 432–436.
11. [11] Polsky, D., Armstrong, K.A., Randall, T.C., Ross, R.N., Even-Shoshan, O., Rosenbaum, P.R., et al. Variation in chemotherapy utilization in ovarian cancer: the relative contribution of geography. Health Serv. Res. 41:6 (2006), 2201–2218.
12. [12] Bristow, R.E., Chang, J., Ziogas, A., Randall, L.M., Anton-Culver, H., High-volume ovarian cancer care: survival impact and disparities in access for advanced-stage disease. Gynecol. Oncol. 132:2 (2014), 403–410.
13. [16] Fleming, S., Schluterman, N.H., Tracy, J.K., Temkin, S.M., Black and white women in Maryland receive different treatment for cervical cancer. PLoS One, 9(8), 2014, e104344.
14. [17] Temkin, S.M., Fleming, S.A., Amrane, S., Schluterman, N., Terplan, M., Geographic disparities amongst patients with gynecologic malignancies at an urban NCI-designated cancer center. Gynecol. Oncol. 137:3 (2015), 497–502.
15. [18] Ramondetta, L.M., Meyer, L.A., Schmeler, K.M., Daheri, M.E., Gallegos, J., Scheurer, M., et al. Avoidable tragedies: disparities in healthcare access among medically underserved women diagnosed with cervical cancer. Gynecol. Oncol. 139:3 (2015), 500–505.
16. [19] Dehaeck, U., McGahan, C.E., Santos, J.L., Carey, M.S., Swenerton, K.D., Kwon, J.S., The impact of geographic variations in treatment on outcomes in ovarian cancer. Int. J. Gynecol. Cancer 23:2 (2013), 282–287.
17. [20] Thrall, M.M., Gray, H.J., Symons, R.G., Weiss, N.S., Flum, D.R., Goff, B.A., Trends in treatment of advanced epithelial ovarian cancer in the Medicare population. Gynecol. Oncol. 122:1 (2011), 100–106.
18. [21] Natale-Pereira, A., Enard, K.R., Nevarez, L., Jones, L.A., The role of patient navigators in eliminating health disparities. Cancer 117:15 Suppl (2011), 3543–3552.
19. [22] Helm, C.W., Ports and complications for intraperitoneal chemotherapy delivery. BJOG 119:2 (2012), 150–159.
20. [23] Petereit, D.G., Molloy, K., Reiner, M.L., Helbig, P., Cina, K., Miner, R., et al. Establishing a patient navigator program to reduce cancer disparities in the American Indian communities of Western South Dakota: initial observations and results. Cancer Control 15:3 (2008), 254–259.
21. [24] Shavers, V.L., Brown, M.L., Racial and ethnic disparities in the receipt of cancer treatment. J. Natl. Cancer Inst. 94:5 (2002), 334–357.